UK markets closed

Protara Therapeutics, Inc. (TARA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
3.4600+0.1200 (+3.61%)
As of 02:17PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
27,594
24,989
16,808
21,088
11,982
Selling general and administrative
18,138
18,624
20,737
26,401
22,462
Total operating expenses
45,732
43,613
37,545
47,489
34,444
Operating income or loss
-45,732
-43,613
-37,545
-47,489
-34,444
Interest expense
-
-
1,137
1,737
34
Total other income/expenses net
262
12
-29,500
-
-
Income before tax
-42,470
-40,420
-65,952
-47,252
-33,978
Income from continuing operations
-42,470
-40,420
-65,952
-47,252
-33,978
Net income
-42,470
-40,420
-65,952
-47,252
-33,978
Net income available to common shareholders
-42,470
-40,420
-65,952
-47,252
-33,978
Basic EPS
-6.13
-3.57
-5.86
-4.21
-4.70
Diluted EPS
-6.13
-3.57
-5.86
-4.21
-4.70
Basic average shares
11,307
11,331
11,260
11,233
7,234
Diluted average shares
11,307
11,331
11,260
11,233
7,234